Harry J. Sacks

机构：Regeneron (United States)

发表论文 144 篇 · 总被引 1486 次 · h-index 21

代表论文

• The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps (2024 · Frontiers in Immunology · 被引 106)
• Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trial (2025 · The Lancet Respiratory Medicine · 被引 83)
• Type 2 Inflammation and Asthma in Children: A Narrative Review (2024 · The Journal of Allergy and Clinical Immunology In Practice · 被引 54)
• Burden of Oral Corticosteroid Use in Severe Asthma: Challenges and Opportunities (2025 · Allergy · 被引 16)
• Effect of dupilumab on mucus burden in patients with moderate-to-severe asthma: the VESTIGE trial (2025 · American Journal of Respiratory and Critical Care Medicine · 被引 14)
• Effect of dupilumab on small airways measured by airway oscillometry in VESTIGE (2025 · Journal of Allergy and Clinical Immunology · 被引 14)